GIORDANO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 6.266
AS - Asia 5.406
EU - Europa 3.697
SA - Sud America 1.538
AF - Africa 371
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 17.301
Nazione #
US - Stati Uniti d'America 6.021
SG - Singapore 2.133
BR - Brasile 1.123
CN - Cina 1.108
VN - Vietnam 954
UA - Ucraina 946
DE - Germania 675
IT - Italia 565
AT - Austria 464
SE - Svezia 265
FR - Francia 256
IN - India 174
AR - Argentina 150
HK - Hong Kong 149
FI - Finlandia 145
TR - Turchia 142
KR - Corea 139
CA - Canada 127
SN - Senegal 118
BD - Bangladesh 97
IQ - Iraq 95
GB - Regno Unito 94
EC - Ecuador 68
ZA - Sudafrica 68
MX - Messico 64
RU - Federazione Russa 61
CO - Colombia 57
PK - Pakistan 56
ID - Indonesia 53
MA - Marocco 53
NL - Olanda 45
VE - Venezuela 38
UZ - Uzbekistan 33
SA - Arabia Saudita 32
BE - Belgio 29
PL - Polonia 28
CL - Cile 27
DZ - Algeria 26
TN - Tunisia 26
JP - Giappone 25
PH - Filippine 25
PY - Paraguay 24
ES - Italia 22
EG - Egitto 21
AZ - Azerbaigian 20
PE - Perù 19
UY - Uruguay 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
JO - Giordania 17
OM - Oman 16
KE - Kenya 15
MY - Malesia 14
BO - Bolivia 13
ET - Etiopia 13
AU - Australia 11
IL - Israele 11
PS - Palestinian Territory 11
IE - Irlanda 10
PA - Panama 10
CR - Costa Rica 9
KW - Kuwait 9
KZ - Kazakistan 9
LT - Lituania 9
DO - Repubblica Dominicana 8
SY - Repubblica araba siriana 8
EU - Europa 7
IR - Iran 7
LB - Libano 7
NP - Nepal 7
QA - Qatar 7
AL - Albania 6
AM - Armenia 6
AO - Angola 6
BH - Bahrain 6
CH - Svizzera 6
GA - Gabon 6
JM - Giamaica 6
NG - Nigeria 6
NI - Nicaragua 6
RO - Romania 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
BY - Bielorussia 4
GE - Georgia 4
LV - Lettonia 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
CI - Costa d'Avorio 3
KG - Kirghizistan 3
MD - Moldavia 3
BN - Brunei Darussalam 2
CD - Congo 2
CY - Cipro 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
Totale 17.262
Città #
Singapore 803
Chandler 684
San Jose 642
Jacksonville 537
Ashburn 459
Dallas 457
Ho Chi Minh City 355
Boardman 321
Vienna 312
San Mateo 307
Dearborn 272
Beijing 263
New York 219
Hanoi 196
Lauterbourg 145
Hong Kong 141
Seoul 137
Shanghai 137
Roxbury 125
Lawrence 124
Dakar 117
Helsinki 109
Izmir 107
Hefei 104
Rende 100
Des Moines 93
São Paulo 88
Munich 83
Los Angeles 79
Ottawa 77
Bremen 65
Brooklyn 63
Ann Arbor 55
Inglewood 53
Guangzhou 52
Da Nang 48
Council Bluffs 46
Grafing 43
Rio de Janeiro 43
Ogden 41
The Dalles 41
Cosenza 40
Haiphong 40
Cambridge 35
Columbus 34
Catanzaro 33
Seattle 31
Baghdad 30
Amsterdam 29
Pune 29
San Francisco 29
Curitiba 28
Santa Clara 28
Tashkent 28
Turku 28
Wilmington 28
Bari 27
Brussels 27
Frankfurt am Main 25
London 24
Orem 24
Tianjin 24
Dhaka 23
Florence 23
Warsaw 23
Brasília 22
Quito 22
Belo Horizonte 21
Biên Hòa 21
Tokyo 21
Toronto 21
Johannesburg 20
Lahore 20
Baku 19
Cape Town 18
Chennai 18
Guayaquil 18
Bắc Ninh 17
Medellín 17
Erbil 16
Hải Dương 16
Buenos Aires 15
Milan 15
Naples 15
Ninh Bình 15
Phoenix 15
Redwood City 15
Amman 14
Hillsboro 14
Montevideo 14
Montreal 14
Stockholm 14
Wuhan 14
Campinas 13
Falls Church 13
Guarulhos 13
Manaus 13
Muscat 13
Thái Bình 13
Thái Nguyên 13
Totale 9.405
Nome #
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 241
Bortezomib-loaded mesoporous silica nanoparticles selectively alter metabolism and induce death in multiple myeloma cells 225
Identification of Breast Cancer Inhibitors Specific for G Protein -Coupled Estrogen Receptor (GPER)-Expressing Cells 210
Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21Cip/WAF1 gene expression in p53-independent manner 209
Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells. 208
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 207
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 203
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 200
Aromatase expression in prepuberal Sertoli cells: Effect of thyroid hormone 188
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 186
Androgen receptor activation inhibits the genomic effect of estradiol in MCF7 cells, a molecular basis of its antiproliferatie action 185
Androgen receptor activation inhibits the genomic effect of estradiol in MCF-7 cells. A molecular basis of its antiproliferative action 183
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 183
Bergapten affects cell survival and induces apoptosis in human breast cancer cells. 181
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 180
Phosphonium Salt Displays Cytotoxic Effects Against Human Cancer Cell Lines 179
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 177
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 174
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 174
Bergapten antagonizes cell survival and induces p53 gene promoter together with p38 MAPK activation in breast cancer cells 172
(2011). Estrogen Receptor beta produces cell death in TCAM2 human seminoma cell line binding through Sp1 on the phosphatase and tensin homologue deleted from chromosome 10 (PTEN) promoter gene. March 17, 2011 25:lb17. ASIP Annual Meeting at Experimental Biology 2011 April 9-13, 2011 - Washington DC – USA, IF:5.043. 172
Valproic acid addresses neuroendocrine differentiation of LNCaP cells and maintains cell survival 171
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 169
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction 169
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 165
A role for the anandamide in human sperm survival 165
Cardiac expression and distribution of nitric oxide synthases in the ventricle of the cold-adapted Antarctic teleosts, the hemoglobinless Chionodraco hamatus and the red-blooded Trematomus bernacchi 163
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 163
Assessment of photo-induced cytotoxic activity of cachrys sicula and cachrys libanotis enriched-coumarin extracts against human melanoma cells 161
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 158
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 157
Aromatase expression in peripuberal Sertoli cells:: effect of thyroid hormone 157
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 157
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 156
Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation 156
Chenodeoxycholic acid through a TGR5-dependent CREB-signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation 155
Recombinant Arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells. 153
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 152
Effect of T3 on aromatase and estrogen receptor contents in peripuberal Sertoli cells 150
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 150
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 148
Cachrys libanotis L. Extracts: Photocytotoxic Effects on UVA-Irradiated Human Melanoma Cells 148
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 148
Ischemic Preconditioning Modulates the Peripheral Innate Immune System to Promote Anti-Inflammatory and Protective Responses in Mice Subjected to Focal Cerebral Ischemia 141
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 140
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells 138
Evidences that leptin upregulates E-cadherin expression in breast cancer and promotes tumor cell growth and progression 138
Effetti del TGF-β e del Bergaptene in line cellular di tumore mammario umano ERα(+) ed ERα(-) 137
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 135
Identification of G protein-coupled estrogen receptor in human and pig spermatozoa. 134
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element 134
Estradiol via estrogen receptor beta influences ROS levels through the transcriptional regulation of SIRT3 in human seminoma TCam-2 cells.doi: 10.1177/1010428317701642.PMID: 28459202 131
Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells 130
Evidence that low doses of taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells 130
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 129
Bergapten inducing proteasome-dependent degradation of estrogen receptor alpha overcome breast cancer tamoxifen-resistance 127
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 126
A translational approach to micro-inflammation in End Stage Renal Disease: molecular effects of low levels of Interleukin 6 126
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth. 123
Combining dextran conjugates with stimuli-responsive and folate-targeting activity: A new class of multifunctional nanoparticles for cancer therapy 123
Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation 122
A Notch inhibitor plus Resveratrol induced blockade of autophagy drives glioblastoma cell death by promoting a switch to apoptosis 119
Nanostructured Hybrid Carriers of Silica and Modified Polymers: A New Frontier For Chemotherapeutic Drugs 118
Olive leaf extract counteracts epithelial to mesenchymal transition process induced by peritoneal dialysis, through the inhibition of TGFβ1 signaling 118
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment 117
Bergapten inducing proteasome-dependent degradation of estrogen receptor alpha may overcome breast cancer tamoxifen-resistance 117
Expression of oestrogen receptors (GPER, ESR1, ESR2) in human ductuli efferentes and proximal epididymis 116
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 115
Effect of T3 on aromatase and estrogen receptor content in peripuberal Sertoli cells 115
The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure 114
CCN6 suppresses metaplastic breast carcinoma by antagonizing WNT/β-catenin signaling to inhibit EZH2-driven EMT 114
Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1 114
RUOLO DELLE VARIANTI DELLA PROTEINA DI MATRICE DI HIV-1 P17 SULLE CELLULE DI TUMORE MAMMARIO 113
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 112
Oxidative Imbalance and Kidney Damage in Cafeteria Diet-Induced Rat Model of Metabolic Syndrome: Effect of Bergamot Polyphenolic Fraction 112
Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer 110
Fsh-r human early male genital tract, testicular tumors and sperm: Its involvement in testicular disorders 110
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 107
Dermal-epidermal membrane systems by using human keratinocytes and mesenchymal stem cells isolated from dermis. 105
Progesterone Receptor B recruits a repressor complex to a half-PRE site of the Estrogen Receptor alfa gene promoter 103
Poncirus trifoliata (L.) Raf. Seed Extract Induces Cell Cycle Arrest and Apoptosis in the Androgen Receptor Positive LNCaP Prostate Cancer Cells 103
Experimental testing of a mathematical model relevant to the extrinsic pathway of apoptosis 102
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts 101
Hybrid Nanoparticles Based on Mesoporous Silica and Functionalized Biopolymers as Drug Carriers for Chemotherapeutic Agents 100
ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure 100
Effects of triiodothyronine (T3) on alternative splicing events in the coding region of P450 aromatase in immature Sertoli cells. 100
Down-regulatory effect of antiestrogens on IRS-1 substrate of insulin signalling pathway in hormone-dependent and hormone-independent MCF-7 derived cell lines 98
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 98
Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland. 97
Evidences that Bercapten is an antitumoral agent that enhances p53 gene expression independently of its photoactivation 96
Role of E2/ERs on the regulation of phosphatase and tensin homolog gene (PTEN) in TCAM2 human seminoma cell line. 96
Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signalling in human breast cancer cells 95
Evidences that bergapten is an antitumoral agent enhances p53 gene expression independently of its photoactivation. 94
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 94
Functional interactions between extracellular matrix proteins and estrogen receptor in modulating adhesion and motility in breast cancer cell line 93
Effects of triiodothyronine (T3) on alternative splicing events in the coding region of P450 aromatase in immature rat Sertoli cells. 92
Identification of ERβ1 and ERβ2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia 92
Polymeric membranes modulate human keratinocyte differentiation in specific epidermal layers. 90
Valproic acid inhibits cell growth in both MCF‑7 and MDA‑MB231 cells by triggering different responses in a cell type‑specific manner 89
Bergapten inducing proteasome-dependent degradation of ERalpha may overcome breast cancer tamoxifen-resistance 89
Totale 13.940
Categoria #
all - tutte 89.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 0 0 0 126 28 98
2021/20221.552 18 241 8 102 164 52 8 323 19 21 231 365
2022/20231.837 260 250 93 204 260 156 33 193 165 37 108 78
2023/20241.324 148 58 83 60 81 324 53 83 100 57 54 223
2024/20252.802 220 342 60 203 134 134 214 162 454 227 237 415
2025/20267.550 921 380 831 606 1.523 620 1.005 456 659 549 0 0
Totale 17.558